Hematology/Oncology News

The detection of specific genomic alterations in circulating tumor DNA appeared linked to poorer outcomes among women with metastatic breast cancer, according to study results.

The FDA has approved obecabtagene autoleucel for the treatment of adults with relapsed refractory B-cell precursor acute lymphoblastic leukemia.

PHILADELPHIA— AI-assisted-colonoscopy significantly increased the number of colonoscopy procedures in which only benign lesions were removed without additional adenomatous polyps, according to data at the ACG Annual Scientific Meeting.

Healio spoke with John Molina, MD, MEd, about research on the use of minimal residual disease testing in acute lymphoblastic leukemia presented at Society of Hematologic Oncology Annual Meeting.

A shortened adjuvant chemotherapy regimen improved outcomes for infants with unilateral pathologic high-risk retinoblastoma, according to study results.

When referring to individuals with cancer, emphasizing the person rather than the condition improves patient morale and refocuses clinicians on the mission of patient-centered care, according to an opinion paper published in JAMA Oncology.

A novel therapeutic approach could intercept rogue cancer cells before they develop into brain metastases, according to study findings.

Both colonoscopies and stool-based tests for colorectal cancer screening may be more efficient and cost-effective compared with blood-based tests, study findings published in Annals of Internal Medicine showed.

Higher omega-3 and omega-6 fatty acid levels may help reduce cancer risk, according to study findings.

ASH has named four new members to its executive committee beginning immediately after the 2024 ASH Annual Meeting.